article thumbnail

Inside the European mass shift to data-driven health solutions

Pharmaceutical Technology

This project centres around the use of electronic health records (EHRs) from different European countries to drive research and improve responses to expected and unexpected crises. EHR , or electronic medical records (EMR), have been adopted in multiple countries worldwide over the last few decades.

article thumbnail

European Health Data Space (EHDS) update: what this means for pharmaceutical and biotech

pharmaphorum

The intention is to streamline the process for patients wishing to access their medical records via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted and secure way that preserves privacy. When will it come into force?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Blockchain: Ready to revolutionise medicinal cannabis research?

pharmaphorum

For example, researchers have long desired access to a comprehensive database of electronic medical records (EMRs). billion by 2025. Previously, a lack of security, transparency, and standardisation has kept such a system from being fully viable in the market or safe to protect patient privacy. The right tool for a big job.

article thumbnail

The Use of Artificial Intelligence in the Pharmaceutical Industry

Viseven

A specifically tuned neural network can keep data secure and manage electronic medical records (EMR) to store patients’ sensitive information and treatment records. Apart from gathering and processing supersensitive information, modern AI technologies can manage clinical data storage and organization. Clinical Trials.

article thumbnail

Influence of 5G on Healthcare

Viseven

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. And when that data is as sensitive as medical records, the security risks increase exponentially.

article thumbnail

Health Data Management: Everything You Need to Know

Viseven

According to the Deloitte report , the volume of health data rose by 40% between 2010 and 2020 and is predicted to climb even higher by 23% by 2025. It outlines how medical data should be used, protected, and disclosed. Pharma companies deal with enormous amounts of health data.

article thumbnail

Unlocking disease treatment with large-scale research

pharmaphorum

The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025. It is estimated that this will reach 70% by 2035. Industry interest. Breakthroughs to come.